Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cells.

Authors
Type
Published Article
Journal
Cancer Letters
0304-3835
Publisher
Elsevier
Publication Date
Volume
364
Issue
1
Pages
70–78
Identifiers
DOI: 10.1016/j.canlet.2015.04.028
PMID: 25937299
Source
Medline
Keywords
  • Autophagy
  • Bkm120
  • Lung Cancer
  • Mek162

Abstract

Statistics

Seen <100 times